Ep127: Jeb Keiper on Computational Drug Discovery

The Long Run with Luke Timmerman - A podcast by Timmerman Report

Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.